Susceptibility to CD8 T-cell-mediated killing influences the reservoir of latently HIV-1-infected CD4 T cells
- PMID: 23846565
- PMCID: PMC3874432
- DOI: 10.1097/QAI.0b013e3182a1bc81
Susceptibility to CD8 T-cell-mediated killing influences the reservoir of latently HIV-1-infected CD4 T cells
Abstract
Background: HIV-1 establishes a lifelong infection in the human body, but host factors that influence viral persistence remain poorly understood. Cell-intrinsic characteristics of CD4 T cells, the main target cells for HIV-1, may affect the composition of the latent viral reservoir by altering the susceptibility to CD8 T-cell-mediated killing.
Results: We observed that susceptibilities of CD4 T cells to CD8 T-cell-mediated killing, as determined in direct ex vivo assays, were significantly higher in persons with natural control of HIV-1 (elite controllers) than in individuals effectively treated with antiretroviral therapy. These differences were most pronounced in naive and in terminally differentiated CD4 T cells and corresponded to a reduced viral reservoir size in elite controllers. Interestingly, the highest susceptibility to CD8 T-cell-mediated killing and lowest reservoirs of cell-associated HIV-1 DNA was consistently observed in elite controllers expressing the protective HLA class I allele B57.
Conclusions: These data suggest that the functional responsiveness of host CD4 T cells to cytotoxic effects of HIV-1-specific CD8 T cells can contribute to shaping the structure and composition of the latently infected CD4 T-cell pool.
Conflict of interest statement
None of the authors declare a conflict of interest related to this work.
Figures




Similar articles
-
Killing of Latently HIV-Infected CD4 T Cells by Autologous CD8 T Cells Is Modulated by Nef.Front Immunol. 2018 Sep 11;9:2068. doi: 10.3389/fimmu.2018.02068. eCollection 2018. Front Immunol. 2018. PMID: 30254642 Free PMC article.
-
Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):253-8. doi: 10.1073/pnas.98.1.253. Proc Natl Acad Sci U S A. 2001. PMID: 11136258 Free PMC article.
-
Primary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+ T cells.Retrovirology. 2013 Jul 1;10:68. doi: 10.1186/1742-4690-10-68. Retrovirology. 2013. PMID: 23816179 Free PMC article.
-
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665. Annu Rev Immunol. 2000. PMID: 10837072 Review.
-
HIV controllers: a multifactorial phenotype of spontaneous viral suppression.Clin Immunol. 2011 Oct;141(1):15-30. doi: 10.1016/j.clim.2011.07.007. Epub 2011 Aug 4. Clin Immunol. 2011. PMID: 21865089 Free PMC article. Review.
Cited by
-
Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4+ T Cells.J Virol. 2019 Nov 26;93(24):e00969-19. doi: 10.1128/JVI.00969-19. Print 2019 Dec 15. J Virol. 2019. PMID: 31578289 Free PMC article.
-
HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.Retrovirology. 2016 Jan 5;13:1. doi: 10.1186/s12977-015-0234-9. Retrovirology. 2016. PMID: 26728316 Free PMC article.
-
The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells.J Clin Invest. 2022 Apr 1;132(7):e154422. doi: 10.1172/JCI154422. J Clin Invest. 2022. PMID: 35133986 Free PMC article.
-
Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells.PLoS Pathog. 2020 Mar 20;16(3):e1008442. doi: 10.1371/journal.ppat.1008442. eCollection 2020 Mar. PLoS Pathog. 2020. PMID: 32196533 Free PMC article.
-
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection.Clin Infect Dis. 2017 Jun 15;64(12):1686-1695. doi: 10.1093/cid/cix201. Clin Infect Dis. 2017. PMID: 28329286 Free PMC article. Clinical Trial.
References
-
- Trono D, Van Lint C, Rouzioux C, Verdin E, Barre-Sinoussi F, Chun TW, Chomont N. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals. Science. 2010;329:174–180. - PubMed
-
- Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science. 2009;323:1304–1307. - PubMed
-
- Wightman F, Solomon A, Khoury G, Green JA, Gray L, Gorry PR, et al. Both CD31(+) and CD31(-) naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy. J Infect Dis. 2010;202:1738–1748. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials